Two new books look at how Johnson & Johnson for decades put profits ahead of patients – including with contaminated baby power and faulty hip implants – and expose the failures of pharmaceutical regulation in India and the United States
At our edit meeting this Wednesday, we debated what should be highlighted as the main story in this newsletter. Should we talk about the broader implications of Sonam Wangchuk’s
This week in Himal
This week, as part of our “Pills, Perils, Profits” investigative series on Southasian pharma, health reporter Vidya Krishnan writes that US aid cuts have exposed the
US and Western aid cuts expose global health’s rotten core and leave millions facing preventable deaths from HIV, TB, malaria and more – but the past and the present offer lessons in how to fight back
As India reveals massive undercounting of coronavirus deaths, a health journalist reminds us of the pandemic’s horrors and the Modi government’s terrible decisions that cost millions of lives
As climate change-driven extreme heat threatens more and more of India’s massive population, ineffective advisories and undercounting of heat-related deaths leave millions vulnerable and unaware of the real risks
This week in Himal
This week, Frances Harrison revisits the Batalanda Commission Report detailing human rights abuses at the torture site in Sri Lanka during the leftist Janatha Vimukthi Peramuna
This week in Himal
This week, Vidya Krishnan and Arshu John write about serious lapses in India’s drug regulatory powers that lead to substandard drugs being made and released
The abrupt and cruel cutting off of USAID without a timeline for its withdrawal is designed to create complete instability and chaos in recipient countries, including in Southasia, says the development economist
This week in Himal
This week, Burhan Majid writes that India’s left liberal elite have worked to obscure Kashmir’s assertion of political rights and autonomy through a focus
Deadly Indian cough syrups in The Gambia and beyond point to shocking disparities in drug regulation for the world’s rich and poor, with the World Health Organisation failing to protect vulnerable countries
